Search - tctmd.com

Displaying 1 - 20 of 244

Sort: Relevancy | Date

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2025

Caitlin E. Cox

December 01, 2025

News Opinion CV Team Dispatch

November 2025 Dispatch for the CV Team

L.A. McKeown

November 24, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2025

Caitlin E. Cox

November 03, 2025

News Conference News TCT 2025

Sirolimus-Coated Balloon Meets Mark in De Novo Lesions and ISR: SELUTION

Michael O'Riordan

October 26, 2025

News Opinion Editor's Corner TCT 2025

What’s Going to Be Hot at TCT 2025

Michael O'Riordan

October 09, 2025

News Opinion CV Team Dispatch

August 2025 Dispatch for the CV Team

L.A. McKeown

August 22, 2025

News Daily News

Coronary DCB Works Well in Multilayer In-Stent Restenosis: AGENT IDE Subanalysis

L.A. McKeown

August 12, 2025

News Industry News

Concept Medical Announces First Patient Enrollment in MAGICAL-SV IDE Trial, Expanding its Coronary Clinical Program Across the U.S. and Europe

August 01, 2025

News Industry News

Fondazione Ricerca e Innovazione Cardiovascolare Completes Enrollment in TRANSFORM II RCT, A landmark study comparing MagicTouch SCB vs DES in Native Coronary Vessels

June 12, 2025

News Conference News CRT 2025

AGENT IDE: DCB Performance for In-Stent Restenosis Lasts Out to 2 Years

L.A. McKeown

March 10, 2025

Presentation CTO 2025

Subintimal Plaque Modification and Neo-Lumen Creation for Management of Resistant In-Stent Restenosis

Presenter: Omar Abdelhai

February 28, 2025

Presentation CTO 2025

Hydrodynamic Contrast Recanalization of Chronically Occluded In-stent Restenosis

Presenter: Brian Li

February 28, 2025

News Daily News

Top Coronary Artery Disease News in 2024

Michael O'Riordan

December 26, 2024

Presentation TCT 2024

TCT 500: Long-term Outcomes and Predictor of Target Lesion Revascularization the Patients After Treated With Paclitaxel Coated Balloon for Drug-Eluted Stent Restenosis

Presenter: Ikuta Akihiro

October 29, 2024

Presentation TCT 2024

TCT 498: Predictors of Larger Final Lumen Expansion After Treatment of In-Stent Restenosis With Fibrotic Neointimal Hyperplasia

Presenter: Takehiko Kido

October 29, 2024

Presentation TCT 2024

TCT 499: Predictors of Good Final Lumen Expansion After Treatment of Severe In-Stent Restenosis Neoatherosclerosis as Evaluated by Intravascular Ultrasound

Presenter: Takehiko Kido

October 29, 2024

Presentation TCT 2024

TCT 501: Paclitaxel-Coated Balloon vs. Uncoated Balloon Angioplasty for Coronary In-Stent Restenosis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Presenter: Dealla Samadi

October 29, 2024

Presentation TCT 2024

TCT 502: Nicotine Inhibits Re-Endothelialization and Promotes Inflammation and Neoatherosclerosis After Drug-Eluting Stent Implantation in a Swine Model

Presenter: Seok Oh

October 29, 2024

Presentation TCT 2024

TCT 495: The Impact of Cutting Balloon Pre-Dilation on the Outcomes of Paclitaxel Drug-Coated Balloon Treatment for Coronary In-Stent Restenosis

Presenter: Yuanji Ma

October 29, 2024

Presentation TCT 2024

TCT 496: Long-term Clinical Outcomes of Drug-Coated Balloons for the Treatment of In-Stent Chronic Total Occlusions

Presenter: Jiasheng Yin

October 29, 2024

Advertisement

TCTMD’s Top 10 Most Popular Stories for November 2025

November 2025 Dispatch for the CV Team

TCTMD’s Top 10 Most Popular Stories for October 2025

Sirolimus-Coated Balloon Meets Mark in De Novo Lesions and ISR: SELUTION

What’s Going to Be Hot at TCT 2025

August 2025 Dispatch for the CV Team

Coronary DCB Works Well in Multilayer In-Stent Restenosis: AGENT IDE Subanalysis

Concept Medical Announces First Patient Enrollment in MAGICAL-SV IDE Trial, Expanding its Coronary Clinical Program Across the U.S. and Europe

Fondazione Ricerca e Innovazione Cardiovascolare Completes Enrollment in TRANSFORM II RCT, A landmark study comparing MagicTouch SCB vs DES in Native Coronary Vessels

AGENT IDE: DCB Performance for In-Stent Restenosis Lasts Out to 2 Years

Subintimal Plaque Modification and Neo-Lumen Creation for Management of Resistant In-Stent Restenosis

Hydrodynamic Contrast Recanalization of Chronically Occluded In-stent Restenosis

Top Coronary Artery Disease News in 2024

TCT 500: Long-term Outcomes and Predictor of Target Lesion Revascularization the Patients After Treated With Paclitaxel Coated Balloon for Drug-Eluted Stent Restenosis

TCT 498: Predictors of Larger Final Lumen Expansion After Treatment of In-Stent Restenosis With Fibrotic Neointimal Hyperplasia

TCT 499: Predictors of Good Final Lumen Expansion After Treatment of Severe In-Stent Restenosis Neoatherosclerosis as Evaluated by Intravascular Ultrasound

TCT 501: Paclitaxel-Coated Balloon vs. Uncoated Balloon Angioplasty for Coronary In-Stent Restenosis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

TCT 502: Nicotine Inhibits Re-Endothelialization and Promotes Inflammation and Neoatherosclerosis After Drug-Eluting Stent Implantation in a Swine Model

TCT 495: The Impact of Cutting Balloon Pre-Dilation on the Outcomes of Paclitaxel Drug-Coated Balloon Treatment for Coronary In-Stent Restenosis

TCT 496: Long-term Clinical Outcomes of Drug-Coated Balloons for the Treatment of In-Stent Chronic Total Occlusions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content